Ultragenyx Pharmaceutical Inc. buy The Goldman Sachs Group, Inc.
Start price
06.06.24
/
50%
€40.80
Target price
06.06.25
€61.55
Performance (%)
15.69%
Price
15.08.24
€47.00
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 15.69%. This prediction currently runs until 06.06.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 4.036% | 4.036% |
iShares Core DAX® | 2.821% | -1.953% |
iShares Nasdaq 100 | 5.285% | -5.092% |
iShares Nikkei 225® | 3.687% | -4.221% |
iShares S&P 500 | 3.577% | -2.240% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $67.00 price target on the stock, up previously from $56.00.
Ratings data for RARE provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.20
02.08.24
02.08.24
€69.62
02.08.25
02.08.25
2.16%
15.08.24
15.08.24